Chemistry:Anatumomab mafenatox

From HandWiki
Short description: Chemical compound
Anatumomab mafenatox
Monoclonal antibody
TypeFab fragment
SourceMouse
TargetTAG-72
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
  (verify)

Anatumomab mafenatox is a mouse monoclonal antibody studied for the treatment non-small cell lung cancer,[1] which acts as a tumor-targeted superantigen.[2]

It is a fusion protein of a human tumor-associated 5T4 antigen monoclonal IgG1 Fab fragment with an enterotoxin ('mafenatox') of Staphylococcus aureus.[3]

Development was abandoned in 2005.[4]

References

  1. "Active Biotech". http://activebiotech.com/?oid=117&_locale=1. 
  2. "Tumor-Targeted Superantigens". Fusion Protein Technologies for Biopharmaceuticals. 2013. pp. 365–381. doi:10.1002/9781118354599.ch24. ISBN 9781118354599. 
  3. "Drug info". World Health Organization. http://whqlibdoc.who.int/druginfo/INN_1999_list41.pdf. 
  4. "Anatumomab mafenatox". AdisInsight. Springer Nature Switzerland AG. http://adisinsight.springer.com/drugs/800013422.